Reata Pharma (RETA) Tops Q2 EPS by 75c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/28/2026

1. ORCL
2. AVGO
3. CDNS
4. ANT
5. BA
6. SPY
7. META
8. HOOD
9. INTC
10. JBLU

Go back to Reata Pharma (RETA) Tops Q2 EPS by 75c

Reata Pharmaceuticals, Inc. Announces Second Quarter 2022 Financial Results and Provides an Update on Clinical Development Programs

August 8, 2022 6:45 AM EDT

Received Priority Review and Acceptance for Filing of the NDA for Omaveloxolone for Treatment of Patients with Friedreichs Ataxia

Provides Update from FDA Mid-Cycle Communication Meeting on Omaveloxolone for Patients with Friedreichs Ataxia

Announces Results of New Data and Analyses Submitted to FDA

Conference Call With Management on August 8, 2022, at 8:30 a.m. ET

PLANO, Texas--(BUSINESS... More